Outset Medical (OM) Income from Continuing Operations (2019 - 2026)
Outset Medical's (OM) quarterly Income from Continuing Operations came in at 18978000.0 in Q1 2026, up 26.39% year-on-year from 15015029.27 in Q1 2025, and up 2.63% on a QoQ basis from 19491000.0 in Q4 2025.
Outset Medical (OM) Income from Continuing Operations (2019 - 2026) Analysis & Trends
Outset Medical (OM) has 8 years of Income from Continuing Operations data on file, last reported at 18978000.0 in Q1 2026.
- On a quarterly basis, Income from Continuing Operations rose 26.39% year-over-year to 18978000.0 in Q1 2026; TTM through Mar 2026 was 74848000.0, a 34.24% increase from a year earlier, with the FY2025 full-year figure at 81653000.0, up 36.2% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 18978000.0, up from 19491000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for OM reached as high as 17838000.0 in Q3 2025 and fell as low as 46180000.0 in Q3 2023.
- Historically, Income from Continuing Operations has averaged 33197647.06 across 5 years, with a median of 36892000.0 in 2022.
- Across the five-year window, Income from Continuing Operations sank 45.12% in 2022 and surged 46.19% in 2025, its largest moves.
- Year by year, Income from Continuing Operations stood at 41444000.0 in 2022, then gained by 6.86% to 38600000.0 in 2023, then jumped by 33.58% to 25638000.0 in 2024, then grew by 23.98% to 19491000.0 in 2025, then gained by 2.63% to 18978000.0 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 18978000.0 in Q1 2026, 19491000.0 in Q4 2025, and 17838000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | 273.95 Mn |
| 10 | Outset Medical | 76,064.22 | -286.57 Mn | 12.10 Mn | -18.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.98 Mn |
| Dec 31, 2025 | -19.49 Mn |
| Sep 30, 2025 | -17.84 Mn |
| Jun 30, 2025 | -18.54 Mn |
| Mar 31, 2025 | -25.78 Mn |
| Dec 31, 2024 | -25.64 Mn |
| Sep 30, 2024 | -27.94 Mn |
| Jun 30, 2024 | -34.45 Mn |
| Mar 31, 2024 | -39.94 Mn |
| Dec 31, 2023 | -38.60 Mn |
| Sep 30, 2023 | -46.18 Mn |
| Jun 30, 2023 | -44.05 Mn |
| Mar 31, 2023 | -43.97 Mn |
| Dec 31, 2022 | -41.44 Mn |
| Sep 30, 2022 | -40.78 Mn |
| Jun 30, 2022 | -43.84 Mn |
| Mar 31, 2022 | -36.89 Mn |
| Dec 31, 2021 | -41.23 Mn |
| Sep 30, 2021 | -30.47 Mn |
| Jun 30, 2021 | -30.21 Mn |